Maneesh Kumar Misra

Maneesh Kumar Misra

Auto-generated profile, based on publicly available information

Maneesh Kumar Misra

Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Raebareli Road, Lucknow 226014, Uttar Pradesh, India

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JHJill A. Hollenbach
Jill A. Hollenbach
PNPaul J. Norman
Paul J. Norman
LCLisa E. Creary
Lisa E. Creary
VDVincent Damotte
Vincent Damotte
GMGonzalo Montero-Martin
Gonzalo Montero-Martin
JOJorge R. Oksenberg
Jorge R. Oksenberg
Significance: Parkinson’s disease (PD) is a chronic, progressive neurodegenerative disease with both familial and sporadic forms and a clear genetic component. In addition, underlying immunoregulatory dysfunction and inflammatory processes have been implicated in PD pathogenesis. In this study, deep sequencing ofHLAgenes, which encode highly variable cell surface immune receptors, reveals specific variants conferring either risk or protection in PD. Because a history of cigarette smoking is known to be protective in PD, we analyzed the interaction of these genetic variants with smoking history in PD patients and healthy controls and found that the genetic effects are modified by history of cigarette smoking. These results provide a molecular model that explains the unique epidemiology of smoking in PD.

11 December 2017 in Immunology
Verified
Journal Article
Closed access
PDF file
MMManeesh K. Misra
Maneesh K. Misra
VDVincent Damotte
Vincent Damotte
JHJill A. Hollenbach
Jill A. Hollenbach

1 February 2015 in Placenta
Verified
Journal Article
Closed access
DSD. Saxena
D. Saxena
MMM.K. Misra
M.K. Misra
FPF. Parveen
F. Parveen
SPS.R. Phadke
S.R. Phadke
SASuraksha Devi Agrawal
Suraksha Devi Agrawal

16 October 2013 in Tissue Antigens
Verified
Journal Article
Closed access
PDF file
MMM. K. Misra
M. K. Misra
SPS. Prakash
S. Prakash
RKR. Kapoor
R. Kapoor
SPS. K. Pandey
S. K. Pandey
RSR. K. Sharma
R. K. Sharma
SASuraksha Devi Agrawal
Suraksha Devi Agrawal

1 August 2014 in Human Immunology
Verified
Journal Article
Closed access
MMManeesh Kumar Misra
Maneesh Kumar Misra
SPShashi Kant Pandey
Shashi Kant Pandey
RKRakesh Kapoor
Rakesh Kapoor
RSRaj Kumar Sharma
Raj Kumar Sharma
RKRohit Kapoor
Rohit Kapoor
SASuraksha Devi Agrawal
Suraksha Devi Agrawal

1 March 2014 in Journal of Interferon & Cytokine Research
Verified
Journal Article
Closed access
MMManeesh Kumar Misra
Maneesh Kumar Misra
RKRakesh Kapoor
Rakesh Kapoor
SPShashi Kant Pandey
Shashi Kant Pandey
RSRaj Kumar Sharma
Raj Kumar Sharma
SASuraksha Agrawal
Suraksha Agrawal
Cytotoxic T-lymphocyte antigen 4 (CTLA-4) is upregulated in effector-T-cells after activation that may alter signal transduction and subsequently cytokine production. The present study was designed to investigate the impact of CTLA-4 +49 A>G (rs231775), −318 C>T (rs5742909), −658 C>T (rs11571317), −1147 C>T (rs16840252), −1661 A>G (rs4553808), +6230 A>G (rs3087243) SNPs, and microsatellite (AT)n repeat polymorphism among end-stage renal disease (ESRD), acute allograft rejection (AR), and delayed graft function (DGF) cases. In this regard, 350 ESRD patients and 350 controls were included. Polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis method was used for genotyping of CTLA-4 SNPs, while PCR-polyacrylamide gel electrophoresis method was adopted for studying CTLA4 (AT)n polymorphism. The mutant genotype GG of CTLA-4 +49A>G,+6230 A>G, and longer alleles of (AT)n repeats polymorphisms were risk associated with ESRD, AR, and DGF cases. The distribution of haplotype+49G:+6230G and GCTTGG (constructed by using 6 studied SNPs) showed risk association for ESRD, DGF, and AR cases. Further, linkage analysis demonstrated strong to moderate linkage disequilibrium in our study populations. The meta-analysis also revealed risk associations for AR cases against GG genotype of CTLA-4 +49A>G SNP, while CTLA-4 − 318C>T polymorphism showed no correlation against TT genotype among AR cases. Subsequently, no correlation was established against the CTLA-4 − 318C>T, −658 C>T, −1147 C>T, and −1661 A>G SNPs in the promoter region. Survival analysis revealed risk associations against GG genotype of CTLA-4 +49A>G, +6230 A>G SNP's with overall survival (OS), and higher hazard for the OS. These results suggested that CTLA-4 variants might be involved in susceptibility to ESRD, AR, and DGF.